These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3337024)

  • 1. Pharmacodynamics of intravenous procainamide as used during acute electropharmacologic testing.
    Morady F; Kou WH; Schmaltz S; Annesley T; De Buitleir M; Nelson SD; Kushner JA
    Am J Cardiol; 1988 Jan; 61(1):93-8. PubMed ID: 3337024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W; Cho JG; Marchlinski FE
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
    Rials SJ; Britchkow D; Marinchak RA; Kowey PR
    Clin Cardiol; 2000 Mar; 23(3):171-4. PubMed ID: 10761804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of procainamide in patients with ventricular tachyarrhythmias.
    Liem LB; Yee YG; Swerdlow CD; Kates RE
    J Clin Pharmacol; 1988 Nov; 28(11):984-9. PubMed ID: 3243920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of procainamide on the dispersion of recovery of excitability during coronary occlusion.
    Levites R; Haft JI; Calderon J; Venkatachalapathy
    Circulation; 1976 Jun; 53(6):982-4. PubMed ID: 1269135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
    Morady F; DiCarlo LA; Baerman JM; Krol RB
    J Am Coll Cardiol; 1985 Jul; 6(1):179-85. PubMed ID: 4008772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of plasma drug level and the presence of conduction disease on the electrophysiologic effects of procainamide.
    Wyse DG; McAnulty JH; Rahimtoola SH
    Am J Cardiol; 1979 Mar; 43(3):619-26. PubMed ID: 420112
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiologic effects of procainamide, mexiletine, and amiodarone on the transplanted heart. Experimental study.
    Alvarez L; Escudero C; Torralba A; Millán I
    J Thorac Cardiovasc Surg; 1995 May; 109(5):899-904. PubMed ID: 7739250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of procainamide infusions.
    Lima JJ; Goldfarb AL; Conti DR; Golden LH; Bascomb BL; Benedetti GM; Jusko WJ
    Am J Cardiol; 1979 Jan; 43(1):98-105. PubMed ID: 758776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction.
    Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
    Am Heart J; 1989 Oct; 118(4):702-8. PubMed ID: 2801477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic properties of procainamide in man.
    Josephson ME; Caracta AR; Ricciutti MA; Lau SH; Damato AN
    Am J Cardiol; 1974 May; 33(5):596-603. PubMed ID: 4820891
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial uptake and pharmacodynamics of procainamide in patients with coronary heart disease and sustained ventricular tachyarrhythmias.
    Gillis AM; Duff HJ; Mitchell LB; Wyse DG
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1001-6. PubMed ID: 8355178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between repolarization and refractoriness in the human ventricle: cycle length dependence and effect of procainamide.
    Lee RJ; Liem LB; Cohen TJ; Franz MR
    J Am Coll Cardiol; 1992 Mar; 19(3):614-8. PubMed ID: 1538018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-dependent effects of procainamide on His-Purkinje conduction in man.
    Gang ES; Denton TA; Oseran DS; Mandel WJ; Peter T
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1525-9. PubMed ID: 4003294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration.
    Papich MG; Davis LE; Davis CA
    J Vet Pharmacol Ther; 1986 Dec; 9(4):359-69. PubMed ID: 3806778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QRS morphology-dependent pharmacodynamics in multiform ventricular ectopic activity.
    Kessler KM; McAuliffe D; Kozlovskis P; Trohman RG; Zaman L; Castellanos A; Sequeira R; Myerburg RJ
    Am J Cardiol; 1988 Mar; 61(8):563-9. PubMed ID: 3344680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery.
    Ujhelyi MR; Hadsall KZ; Euler DE; Mehra R
    J Cardiovasc Electrophysiol; 2002 Jun; 13(6):605-11. PubMed ID: 12108506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.
    Windle J; Prystowsky EN; Miles WM; Heger JJ
    Clin Pharmacol Ther; 1987 Jun; 41(6):603-10. PubMed ID: 3581646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.